@article{5efaff0664834af296d21374cb714c05,
title = "Low incidence of invasive fungal infections in a large observational cohort of patients initiating IL-17 or IL-23 inhibitor therapy, United States, 2016-2022",
keywords = "Candida infection, Crohn's disease, blastomycosis, brodalumab, candidiasis, coccidioidomycosis, esophageal candidiasis, guselkumab, histoplasmosis, inflammatory bowel disease, interleukin-17 inhibitors, interleukin-23 inhibitors, invasive fungal infection, ixekizumab, psoriasis, risankizumab, secukinumab, tildrakizumab, ustekinumab",
author = "Bahr, \{Nathan C.\} and Kaitlin Benedict and Mitsuru Toda and Gold, \{Jeremy A.W.\} and Lipner, \{Shari R.\}",
year = "2024",
month = jul,
doi = "10.1016/j.jaad.2024.02.045",
language = "English (US)",
volume = "91",
pages = "119--122",
journal = "Journal of the American Academy of Dermatology",
issn = "0190-9622",
publisher = "Elsevier Inc.",
number = "1",
}